_id
69172a503c536f8df2316d96
Ticker
VRAX
Name
Virax Biolabs Group Limited Ordinary Shares
Exchange
NASDAQ
Address
BioCity Glasgow, Lanarkshire, United Kingdom, ML1 5UH
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://viraxbiolabs.com
Description
Virax Biolabs Group Limited, a biotechnology company, distributes diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of T cell in Vitro Diagnostics. The company offers various in-vitro diagnostics test kits comprising respiratory, pregnancy and fertility, infectious diseases, sti, drugs of abuse, oncology, cardiac, women's health, other test kits under the ViraxClear brands; and rapid and molecular tests for small animal veterinary diagnostics under the ViraxVet brand. It also provides ViraxImmune, a T cell In vitro diagnostic device and wellness mobile application; and service, such as antibody engineering, custom peptides, protein sequencing, vaccine efficacy testing, immunology lab services, kits and reagents. In addition, the company is involved in research and development activities; and provision of procurement, warehousing, product development, and staffing management services. It serves research organizations, corporations, independent laboratories, large hospital systems and public and private institutions, as well as distributor customers. The company operates in the United Kingdom, the United States, and China. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was founded in 2013 and is headquartered in Lanarkshire, the United Kingdom.
Last Close
0.4159
Volume
555005
Current Price
0.405
Change
-0.0163
Last Updated
2026-01-08T12:26:12.043Z
Image
https://logo.clearbit.com/viraxbiolabs.com
Ipo Date
2022-07-21T00:00:00.000Z
Market Cap
2848371
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Target Price
3
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
1608
Cost Of Revenue
217022
Gross Profit
-215414
Operating Expenses
2370061
Operating Income
-2585475
Interest Expense
30991
Pretax Income
-2616867
Net Income
-2338771
Eps
-0.49102866405920803
Dividends Per Share
-
Shares Outstanding
7423432
Income Tax Expense
-273594
EBITDA
-2369174
Operating Margin
-160788.24626865672
Total Other Income Expense Net
-31392
Cash
3345464
Short Term Investments
-
Receivables
175697
Inventories
54186
Total Current Assets
4149415
Property Plant Equipment
1565600
Total Assets
5715015
Payables
42373
Short Term Debt
261950
Long Term Debt
-
Total Liabilities
641516
Equity
5311968
Bs_currency_symbol
USD
Depreciation
216701
Change In Working Capital
-623463
Cash From Operations
-2923396
Capital Expenditures
141503
Cash From Investing
-141505
Cash From Financing
2181421
Net Change In Cash
-883480
Cf_currency_symbol
-
PE
-
PB
0.3631453003858457
ROE
-44.02833375502262
ROA
-40.92326966770866
FCF
-3064899
Fcf Percent
-1906.0317164179105
Piotroski FScore
0
Health Score
33
Deep Value Investing Score
7
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
3.5
Growth Investing Score
2
Momentum Investing Score
4
Net Net Investing Score
6
Quality Investing Score
3
Value Investing Score
5.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
1608
Quarters > 0 > income Statement > cost Of Revenue
217022
Quarters > 0 > income Statement > gross Profit
-215414
Quarters > 0 > income Statement > operating Expenses
2370061
Quarters > 0 > income Statement > operating Income
-2585475
Quarters > 0 > income Statement > interest Expense
30991
Quarters > 0 > income Statement > pretax Income
-2616867
Quarters > 0 > income Statement > net Income
-2338771
Quarters > 0 > income Statement > eps
-0.49102866405920803
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
4763003
Quarters > 0 > income Statement > income Tax Expense
-273594
Quarters > 0 > income Statement > EBITDA
-2369174
Quarters > 0 > income Statement > operating Margin
-160788.24626865672
Quarters > 0 > income Statement > total Other Income Expense Net
-31392
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
3345464
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
175697
Quarters > 0 > balance Sheet > inventories
54186
Quarters > 0 > balance Sheet > total Current Assets
4149415
Quarters > 0 > balance Sheet > property Plant Equipment
1565600
Quarters > 0 > balance Sheet > total Assets
5715015
Quarters > 0 > balance Sheet > payables
42373
Quarters > 0 > balance Sheet > short Term Debt
261950
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
641516
Quarters > 0 > balance Sheet > equity
5311968
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-2338771
Quarters > 0 > cash Flow > depreciation
216701
Quarters > 0 > cash Flow > change In Working Capital
-623463
Quarters > 0 > cash Flow > cash From Operations
-2923396
Quarters > 0 > cash Flow > capital Expenditures
141503
Quarters > 0 > cash Flow > cash From Investing
-141505
Quarters > 0 > cash Flow > cash From Financing
2181421
Quarters > 0 > cash Flow > net Change In Cash
-883480
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.49102866405920803
Quarters > 0 > ratios > PB
0.3631453003858457
Quarters > 0 > ratios > ROE
-44.02833375502262
Quarters > 0 > ratios > ROA
-40.92326966770866
Quarters > 0 > ratios > FCF
-3064899
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-1906.0317164179105
Quarters > 0 > health Score
33
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
1378
Quarters > 1 > income Statement > cost Of Revenue
47971
Quarters > 1 > income Statement > gross Profit
-46593
Quarters > 1 > income Statement > operating Expenses
3237413
Quarters > 1 > income Statement > operating Income
-3284006
Quarters > 1 > income Statement > interest Expense
32588
Quarters > 1 > income Statement > pretax Income
-3310668
Quarters > 1 > income Statement > net Income
-3304820
Quarters > 1 > income Statement > eps
-0.7584834278983793
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
4357142
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-3139405
Quarters > 1 > income Statement > operating Margin
-238316.8359941945
Quarters > 1 > income Statement > total Other Income Expense Net
-26662
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
4228944
Quarters > 1 > balance Sheet > short Term Investments
94190
Quarters > 1 > balance Sheet > receivables
30654
Quarters > 1 > balance Sheet > inventories
94675
Quarters > 1 > balance Sheet > total Current Assets
4893655
Quarters > 1 > balance Sheet > property Plant Equipment
1533248
Quarters > 1 > balance Sheet > total Assets
6426903
Quarters > 1 > balance Sheet > payables
56093
Quarters > 1 > balance Sheet > short Term Debt
85461
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
964750
Quarters > 1 > balance Sheet > equity
5696120
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-3304820
Quarters > 1 > cash Flow > depreciation
185196
Quarters > 1 > cash Flow > change In Working Capital
-107628
Quarters > 1 > cash Flow > cash From Operations
-2454692
Quarters > 1 > cash Flow > capital Expenditures
355895
Quarters > 1 > cash Flow > cash From Investing
-355895
Quarters > 1 > cash Flow > cash From Financing
-246460
Quarters > 1 > cash Flow > net Change In Cash
-3057047
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.7584834278983793
Quarters > 1 > ratios > PB
0.3097972848184378
Quarters > 1 > ratios > ROE
-58.01879173893808
Quarters > 1 > ratios > ROA
-51.42165674509168
Quarters > 1 > ratios > FCF
-2810587
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-2039.6132075471698
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2024-09-30
Quarters > 2 > income Statement > revenue
4953
Quarters > 2 > income Statement > cost Of Revenue
11427
Quarters > 2 > income Statement > gross Profit
-6474
Quarters > 2 > income Statement > operating Expenses
2872417
Quarters > 2 > income Statement > operating Income
-2878891
Quarters > 2 > income Statement > interest Expense
25591
Quarters > 2 > income Statement > pretax Income
-2893225
Quarters > 2 > income Statement > net Income
-2756427
Quarters > 2 > income Statement > eps
-0.8881523493081476
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
3103552
Quarters > 2 > income Statement > income Tax Expense
-136661
Quarters > 2 > income Statement > EBITDA
-2766804
Quarters > 2 > income Statement > operating Margin
-58124.18736119523
Quarters > 2 > income Statement > total Other Income Expense Net
-14334
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
7285991
Quarters > 2 > balance Sheet > short Term Investments
95546
Quarters > 2 > balance Sheet > receivables
26155
Quarters > 2 > balance Sheet > inventories
261299
Quarters > 2 > balance Sheet > total Current Assets
8033334
Quarters > 2 > balance Sheet > property Plant Equipment
1363417
Quarters > 2 > balance Sheet > total Assets
9442944
Quarters > 2 > balance Sheet > payables
118945
Quarters > 2 > balance Sheet > short Term Debt
271104
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1026068
Quarters > 2 > balance Sheet > equity
8644995
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-2756427
Quarters > 2 > cash Flow > depreciation
158191
Quarters > 2 > cash Flow > change In Working Capital
266393
Quarters > 2 > cash Flow > cash From Operations
-1918624
Quarters > 2 > cash Flow > capital Expenditures
247995
Quarters > 2 > cash Flow > cash From Investing
-247995
Quarters > 2 > cash Flow > cash From Financing
5863366
Quarters > 2 > cash Flow > net Change In Cash
3696747
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.8881523493081476
Quarters > 2 > ratios > PB
0.14539494354826119
Quarters > 2 > ratios > ROE
-31.88465696047251
Quarters > 2 > ratios > ROA
-29.190335132772155
Quarters > 2 > ratios > FCF
-2166619
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-437.43569553805776
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-06-30
Quarters > 3 > income Statement > revenue
79919
Quarters > 3 > income Statement > cost Of Revenue
39847
Quarters > 3 > income Statement > gross Profit
40072
Quarters > 3 > income Statement > operating Expenses
3830322
Quarters > 3 > income Statement > operating Income
-3790250
Quarters > 3 > income Statement > interest Expense
16764
Quarters > 3 > income Statement > pretax Income
-3824916
Quarters > 3 > income Statement > net Income
-3823885
Quarters > 3 > income Statement > eps
-1.7089652762135628
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
2237544
Quarters > 3 > income Statement > income Tax Expense
-1031
Quarters > 3 > income Statement > EBITDA
-3722775
Quarters > 3 > income Statement > operating Margin
-4742.614397077041
Quarters > 3 > income Statement > total Other Income Expense Net
-34666
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
3589244
Quarters > 3 > balance Sheet > short Term Investments
77321
Quarters > 3 > balance Sheet > receivables
217843
Quarters > 3 > balance Sheet > inventories
60383
Quarters > 3 > balance Sheet > total Current Assets
4380252
Quarters > 3 > balance Sheet > property Plant Equipment
1103717
Quarters > 3 > balance Sheet > total Assets
5483969
Quarters > 3 > balance Sheet > payables
45631
Quarters > 3 > balance Sheet > short Term Debt
47955
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
345194
Quarters > 3 > balance Sheet > equity
5366757
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-3823885
Quarters > 3 > cash Flow > depreciation
85380
Quarters > 3 > cash Flow > change In Working Capital
82234
Quarters > 3 > cash Flow > cash From Operations
-2789353
Quarters > 3 > cash Flow > capital Expenditures
459921
Quarters > 3 > cash Flow > cash From Investing
-456268
Quarters > 3 > cash Flow > cash From Financing
1726983
Quarters > 3 > cash Flow > net Change In Cash
-1518638
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-1.7089652762135628
Quarters > 3 > ratios > PB
0.16885529193887483
Quarters > 3 > ratios > ROE
-71.25131620455333
Quarters > 3 > ratios > ROA
-69.728421148989
Quarters > 3 > ratios > FCF
-3249274
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-40.65709030393273
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2025-03-31
Annuals > 0 > income Statement > revenue
6331
Annuals > 0 > income Statement > cost Of Revenue
59398
Annuals > 0 > income Statement > gross Profit
-53067
Annuals > 0 > income Statement > operating Expenses
6109830
Annuals > 0 > income Statement > operating Income
-6162897
Annuals > 0 > income Statement > interest Expense
58179
Annuals > 0 > income Statement > pretax Income
-6203893
Annuals > 0 > income Statement > net Income
-6061247
Annuals > 0 > income Statement > eps
-1.9530032040706906
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
3103552
Annuals > 0 > income Statement > income Tax Expense
-136661
Annuals > 0 > income Statement > EBITDA
-5802327
Annuals > 0 > income Statement > operating Margin
-97344.76386036961
Annuals > 0 > income Statement > total Other Income Expense Net
-40996
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
4228944
Annuals > 0 > balance Sheet > short Term Investments
94190
Annuals > 0 > balance Sheet > receivables
30654
Annuals > 0 > balance Sheet > inventories
94675
Annuals > 0 > balance Sheet > total Current Assets
4893655
Annuals > 0 > balance Sheet > property Plant Equipment
1533248
Annuals > 0 > balance Sheet > total Assets
6426903
Annuals > 0 > balance Sheet > payables
56093
Annuals > 0 > balance Sheet > short Term Debt
85461
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
964750
Annuals > 0 > balance Sheet > equity
5696120
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-6067232
Annuals > 0 > cash Flow > depreciation
343387
Annuals > 0 > cash Flow > change In Working Capital
625617
Annuals > 0 > cash Flow > cash From Operations
-4563576
Annuals > 0 > cash Flow > capital Expenditures
603890
Annuals > 0 > cash Flow > cash From Investing
-603890
Annuals > 0 > cash Flow > cash From Financing
5807166
Annuals > 0 > cash Flow > net Change In Cash
639700
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-1.9530032040706906
Annuals > 0 > ratios > PB
0.22066574440145223
Annuals > 0 > ratios > ROE
-106.41010020856302
Annuals > 0 > ratios > ROA
-94.31054117356369
Annuals > 0 > ratios > FCF
-5167466
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-816.2163955141368
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2024-03-31
Annuals > 1 > income Statement > revenue
156419
Annuals > 1 > income Statement > cost Of Revenue
105829
Annuals > 1 > income Statement > gross Profit
50590
Annuals > 1 > income Statement > operating Expenses
6547063
Annuals > 1 > income Statement > operating Income
-6496473
Annuals > 1 > income Statement > interest Expense
26878
Annuals > 1 > income Statement > pretax Income
-6739120
Annuals > 1 > income Statement > net Income
-6733537
Annuals > 1 > income Statement > eps
-3.3560057894332873
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
2006414
Annuals > 1 > income Statement > income Tax Expense
-194474
Annuals > 1 > income Statement > EBITDA
-6609144
Annuals > 1 > income Statement > operating Margin
-4153.250564189772
Annuals > 1 > income Statement > total Other Income Expense Net
-242647
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
3589244
Annuals > 1 > balance Sheet > short Term Investments
77321
Annuals > 1 > balance Sheet > receivables
217843
Annuals > 1 > balance Sheet > inventories
60383
Annuals > 1 > balance Sheet > total Current Assets
4380252
Annuals > 1 > balance Sheet > property Plant Equipment
1103717
Annuals > 1 > balance Sheet > total Assets
5483969
Annuals > 1 > balance Sheet > payables
45631
Annuals > 1 > balance Sheet > short Term Debt
47955
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
345194
Annuals > 1 > balance Sheet > equity
5366757
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-6739120
Annuals > 1 > cash Flow > depreciation
103099
Annuals > 1 > cash Flow > change In Working Capital
-1120029
Annuals > 1 > cash Flow > cash From Operations
-6247016
Annuals > 1 > cash Flow > capital Expenditures
1164449
Annuals > 1 > cash Flow > cash From Investing
-1164449
Annuals > 1 > cash Flow > cash From Financing
1648171
Annuals > 1 > cash Flow > net Change In Cash
-5763294
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-3.3560057894332873
Annuals > 1 > ratios > PB
0.15141316627527573
Annuals > 1 > ratios > ROE
-125.46752163364208
Annuals > 1 > ratios > ROA
-122.78583266973244
Annuals > 1 > ratios > FCF
-7411465
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-47.38212749090584
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2023-03-31
Annuals > 2 > income Statement > revenue
8561
Annuals > 2 > income Statement > cost Of Revenue
9926
Annuals > 2 > income Statement > gross Profit
-1365
Annuals > 2 > income Statement > operating Expenses
5731396
Annuals > 2 > income Statement > operating Income
-5732760
Annuals > 2 > income Statement > interest Expense
15468
Annuals > 2 > income Statement > pretax Income
-5457763
Annuals > 2 > income Statement > net Income
-5457494
Annuals > 2 > income Statement > eps
-5.134131025613768
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1062983
Annuals > 2 > income Statement > income Tax Expense
-271
Annuals > 2 > income Statement > EBITDA
-5442291
Annuals > 2 > income Statement > operating Margin
-66963.6724681696
Annuals > 2 > income Statement > total Other Income Expense Net
274998
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
9352538
Annuals > 2 > balance Sheet > short Term Investments
49257
Annuals > 2 > balance Sheet > receivables
-24095
Annuals > 2 > balance Sheet > inventories
24095
Annuals > 2 > balance Sheet > total Current Assets
9634013
Annuals > 2 > balance Sheet > property Plant Equipment
0
Annuals > 2 > balance Sheet > total Assets
9812416
Annuals > 2 > balance Sheet > payables
159908
Annuals > 2 > balance Sheet > short Term Debt
146250
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
908401
Annuals > 2 > balance Sheet > equity
9126414
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-5457494
Annuals > 2 > cash Flow > depreciation
0
Annuals > 2 > cash Flow > change In Working Capital
-216275
Annuals > 2 > cash Flow > cash From Operations
-4179767
Annuals > 2 > cash Flow > capital Expenditures
178403
Annuals > 2 > cash Flow > cash From Investing
-178403
Annuals > 2 > cash Flow > cash From Financing
13688952
Annuals > 2 > cash Flow > net Change In Cash
9330782
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-5.134131025613768
Annuals > 2 > ratios > PB
0.0471716618378259
Annuals > 2 > ratios > ROE
-59.798887054652575
Annuals > 2 > ratios > ROA
-55.61824936896274
Annuals > 2 > ratios > FCF
-4358170
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-509.07253825487675
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2022-03-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
0
Annuals > 3 > income Statement > gross Profit
0
Annuals > 3 > income Statement > operating Expenses
1733679
Annuals > 3 > income Statement > operating Income
-1733680
Annuals > 3 > income Statement > interest Expense
15438
Annuals > 3 > income Statement > pretax Income
-1749870
Annuals > 3 > income Statement > net Income
-1708827
Annuals > 3 > income Statement > eps
-1.5023856853603232
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1137409
Annuals > 3 > income Statement > income Tax Expense
-1774722
Annuals > 3 > income Statement > EBITDA
-750
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-16191
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
21756
Annuals > 3 > balance Sheet > short Term Investments
5999
Annuals > 3 > balance Sheet > receivables
0
Annuals > 3 > balance Sheet > inventories
20951
Annuals > 3 > balance Sheet > total Current Assets
48706
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
48706
Annuals > 3 > balance Sheet > payables
846474
Annuals > 3 > balance Sheet > short Term Debt
3758
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1245414
Annuals > 3 > balance Sheet > equity
-974578
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-1708827
Annuals > 3 > cash Flow > depreciation
0
Annuals > 3 > cash Flow > change In Working Capital
644390
Annuals > 3 > cash Flow > cash From Operations
-809069
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-178403
Annuals > 3 > cash Flow > cash From Financing
813205
Annuals > 3 > cash Flow > net Change In Cash
4135
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.5023856853603232
Annuals > 3 > ratios > PB
-0.47266677987806005
Annuals > 3 > ratios > ROE
175.34019852695218
Annuals > 3 > ratios > ROA
-3508.4527573604896
Annuals > 3 > ratios > FCF
-809069
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
31
Valuation > metrics > PE
-0.49102866405920803
Valuation > metrics > PB
0.3631453003858457
Valuation > final Score
70
Valuation > verdict
63.7% Undervalued
Profitability > metrics > ROE
-44.02833375502262
Profitability > metrics > ROA
-56.36387297968509
Profitability > metrics > Net Margin
-1454.459577114428
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.12076804679546262
Risk > metrics > Interest Coverage
-83.42663999225582
Risk > final Score
-274
Risk > verdict
High
Liquidity > metrics > Current Ratio
13.634904361484343
Liquidity > metrics > Quick Ratio
13.456850123060038
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-343
Prev Risks > 1
-390
Prev Risks > 2
-844
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:47:32.160Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-12-02
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.49
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.49
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-07-02
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.76
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.76
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-03-31
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-
Earnings History > 2 > eps Estimate
-0.33
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-09-30
Earnings History > 3 > report Date
2024-11-20
Earnings History > 3 > date
2024-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.89
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.89
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-06-30
Earnings History > 4 > report Date
2022-07-21
Earnings History > 4 > date
2022-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.03
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.03
Earnings History > 4 > surprise Percent
-
Virax Biolabs Group Limited, a biotechnology company, distributes diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of T cell in Vitro Diagnostics. The company offers various in-vitro diagnostics test kits comprising respiratory, pregnancy and fertility, infectious diseases, sti, drugs of abuse, oncology, cardiac, women's health, other test kits under the ViraxClear brands; and rapid and molecular tests for small animal veterinary diagnostics under the ViraxVet brand. It also provides ViraxImmune, a T cell In vitro diagnostic device and wellness mobile application; and service, such as antibody engineering, custom peptides, protein sequencing, vaccine efficacy testing, immunology lab services, kits and reagents. In addition, the company is involved in research and development activities; and provision of procurement, warehousing, product development, and staffing management services. It serves research organizations, corporations, independent laboratories, large hospital systems and public and private institutions, as well as distributor customers. The company operates in the United Kingdom, the United States, and China. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was founded in 2013 and is headquartered in Lanarkshire, the United Kingdom.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AVirax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Update Defense World
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$3
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.71% of the total shares of Virax Biolabs Group Limited Ordinary Shares
1.
Citadel Advisors Llc(0.6945%)
since
2025/06/30
2.
Fidelity Nasdaq Composite Index(0.0125%)
since
2025/03/31
3.
Morgan Stanley - Brokerage Accounts(0%)
since
2025/03/31
4.
Royal Bank of Canada(0%)
since
2025/03/31
5.
Tower Research Capital LLC(0%)
since
2025/03/31
6.
R Squared Ltd(0%)
since
2025/03/31
7.
XTX Topco Ltd(0%)
since
2025/03/31
8.
TWO SIGMA SECURITIES, LLC(0%)
since
2025/06/30
9.
HRT FINANCIAL LLC(0%)
since
2025/06/30
10.
Northwestern Mutual Wealth Management Co(0%)
since
2025/03/31
11.
UBS Group AG(0%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.49
EPS Estimate
0
EPS Difference
-0.49
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.